Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on June 3, 2025

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the European launch of OviTex Inguinal …

Merus N.V. Announces Proposed Public Offering of Common Shares
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug …

Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
Best-in-disease profile with JAK-like efficacy and monthly (Q4W) dosing in both three-month placebo-controlled and six-month blinded treatment period Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max …

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer
MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced the appointment of Michael Lawless, an …

Windtree Announces Plan for Cryptocurrency Treasury Policy
WARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …

Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that members of …

HealthEquity Reports First Quarter Ended April 30, 2025 Financial Results
Highlights of the first quarter include: Revenue of $330.8 million, an increase of 15% compared to $287.6 million in Q1 FY25. Net income of $53.9 million, an increase of 87% compared to $28.8 million in Q1 FY25, with non-GAAP net income of $85.8 million, …

Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
VANCOUVER, British Columbia and BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

MSCopilot® receives CE marking under the European Union Medical Device Regulation (EU MDR) 2017/745
A major milestone for the digital monitoring of people living with multiple sclerosis PARIS, FRANCE, FRANCE, June 3, 2025 /EINPresswire.com/ -- On the occasion of World Multiple Sclerosis Day, Ad Scientiam announced that MSCopilot®, its class IIa …

New Report Analyzes South Korea’s Medical Tourism Market 2025–2033 : Advanced Care and K-Wave Fuel Demand
Growing demand for cosmetic, fertility, and affordable treatments to push South Korea’s medical tourism market to USD 3.1B by 2033. TOKYO, JAPAN, June 3, 2025 /EINPresswire.com/ -- The South Korea medical tourism market reached a value of USD 2.0 …

Zest Unveils New App-Based Brain Aging Test to Help Prevent Dementia Decades Before Symptoms Begin
Developed in partnership with the University of Cambridge, the 10-minute PREMAZ assessment is now available for free LONDON, GREATER LONDON, UNITED KINGDOM, June 3, 2025 /EINPresswire.com/ -- Zest, a longevity-focused biotech company, has joined forces …

Healthcare VC Leader Ryan McKindles Brings Founder-Focused Lens to House of Bricks® Advisory Board
Healthcare VC Ryan McKindles joins House of Bricks® to guide founders with deep startup, legal, and investment expertise. BIRMINGHAM, MI, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- House of Bricks®, the execution-first advisory platform for Seed …

Prof. Gang Zheng to Share Insights on Theranostic Lipid Nanoparticles in Exclusive BOC Sciences Webinar
BOC Sciences hosts Prof. Gang Zheng in a groundbreaking webinar on theranostic lipid nanoparticles for cancer medicine. SHIRLEY, NY, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- BOC Sciences announces an upcoming webinar featuring Prof. Gang Zheng, …

Immix Biopharma Announces Primary Endpoint Met in positive NXC-201 Interim Results Presented at ASCO, Enabling Path to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
Immix Biopharma today presented results at ASCO from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201, meeting its primary endpoint. – NXC-201 met primary endpoint with a complete response (CR) rate of 70% (7/10 patients) – – No …

Rising Star Talks about the Importance of Comprehensive Vision Care Treatments
SAN RAFAEL, CA, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Rising Star Optometry, based in San Rafael, California, has been serving the community for over two decades with a focus on comprehensive eye care and vision therapy. Founded by Dr. David …

Rising Star Optometry Highlights the Need for Eye Care Services
SAN RAFAEL, CA, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Rising Star Optometry, based in San Rafael, California, emphasizes the critical role of regular eye care in maintaining overall health. With a history spanning over two decades, the clinic …

Codiant Rolls Out AI-Powered Innovation and IT Staff Augmentation to Empower Business Growth
Codiant, a Leading Provider of Custom Software Development, Introduces Cutting-Edge AI Solutions and Flexible IT Talent to Accelerate Business Success IL, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Codiant, a global leader in custom software …

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book
Biofrontera received patent approval for the revised formulation of Ameluz® in April 2025, extending patent protection through to December 2043. The Orange Book is published by the U.S. Food and Drug Administration (FDA) and lists all approved prescription …

Scientists develop AI method to predict overall survival rate of prostate cancer patients
AI tools can provide close to precise survival estimates of patients with prostate cancer, according to scientists SHARJAH, UNITED ARAB EMIRATES, June 3, 2025 /EINPresswire.com/ -- Scientists say they have worked out a machine learning method with the …

Announcing Collaborative Partnership between Carolina Christian College and Capstone University
UNIVERSITY PLACE, WA, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Capstone University and the Carolina Christian College (CCC) are pleased to announce a strategic collaboration. The Carolina Christian College, with more than 80 years of excellence …